| [1] |
Danaei G,Finucane MM,Lu Y,et al.National,regional,and global trends in fasting plasma glucose and diabetes prevalence since 1980:systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants[J].Lancet,2011,378(9785):31-40.
|
| [2] |
Sun H, Yuan Y, Sun ZL. Cholesterol contributes to diabetic nephropathy through SCAP-SREBP-2 Pathway[J].Int J Endocrinol,2013,2013:592576.
|
| [3] |
Forbes JM,Fukami K,Cooper ME.Diabetic nephropathy:where hemodynamics meets metabolism[J].Exp Clin Endocrinol Diabetes,2007,115(2):69-84.
|
| [4] |
Jerums G, Panagiotopoulos S, Premaratne E, et al. Integrating albuminuria and GFR in the assessment of diabetic nephropathy[J].Nat Rev Nephrol,2009,5(7):397-406.
|
| [5] |
Tramonti G,Kanwar YS.Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy[J].Endocrine,2013,43(3):494-503.
|
| [6] |
Zhang,XF,Tan BK.Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats[J].Acta Pharmacol Sin,2000,21(12):1157-1164.
|
| [7] |
Menini S,Amadio L,Oddi G,et al.Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress[J].Diabetes,2006,55(6):1642-1650.
|
| [8] |
Ji X, Li C, Ou Y, et al. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemiamediated renal oxidative stress and inflammation via Akt/NF-κB pathway[J].Mol Cell Endocrinol,2016,437:268-279.
|
| [9] |
Baynes JW.Role of oxidative stress in development of complications in diabetes[J].Diabetes,1991,40(4):405-412.
|
| [10] |
Giacco F,Brownlee M.Oxidative stress and diabetic complications[J].Circ Res,2010,107(9):1058-1070.
|
| [11] |
Schnackenberg CG.Oxygen radicals in cardiovascular-renal disease[J].Curr Opin Pharmacol,2002,2(2):121-125.
|
| [12] |
Gorin Y,Block K,Hernandez J,et al.Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney[J].J Biol Chem,2005,280(47):39616-39626.
|
| [13] |
Fujii M, Inoguchi T, Maeda Y, et al. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice[J].Kidney Int,2007,72(4):473-480.
|
| [14] |
Sheeja K,Guruvayoorappan C,Kuttan G.Antiangiogenic activity of andrographis paniculata extract and andrographolide[J].Int Immunopharmacol,2007,7(2):211-221.
|
| [15] |
Sinha J, Mukhopadhyay S, Das N, et al. Targeting of liposomal andrographolide to L.donovani-infected macrophages in vivo[J].Drug Deliv,2000,7( 4):209-213.
|
| [16] |
Jada SR,Hamzah AS,Lajis NH,et al.Semisynthesis and cytotoxic activities of andrographolide analogues[J].J Enzyme Inhib Med Chem,2006,21(2):145-155.
|
| [17] |
Zhang Z,Jiang J,Yu P,et al.Hypoglycemic and beta cell protective effects of Andrographolide analogue for diabetes treatment[J].J Transl Med,2009,7:62.
|
| [18] |
Zhang C,Gui L,Xu Y,et al.Preventive effects of Andrographolide on the development of diabetes in autoimmune diabetic NOD mice by inducing immune tolerance[J].Int Immunopharmacol,2013,16(4):451-456.
|
| [19] |
Yan GR,Zhou HH,Wang Y,et al.Protective effects of Andrographolide analogue AL-1 on ROS-induced RIN-mbeta cell death by inducing ROS generation[J].PLoS One,2013,8(6):e63656.
|
| [20] |
Dey SK,Bose D,Hazra A,et al.Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole Andrographolide derivatives[J].PLoS One,2013,8(3):e58055.
|
| [21] |
Zhu YY, Yu G, Zhang Y, et al. A novel Andrographolide derivative AL-1 exerts its cytotoxicity on K562 cells through a ROS-dependent mechanism[J].Proteomics,2013,13(1):169-178.
|
| [22] |
Kaur M,Bedi O,Sachdeva S,et al.Rodent animal models:from mild to advanced stages of diabetic nephropathy[J].Inflammopharmacology,2014,22(5):279-293.
|
| [23] |
Fang WH.Drug treatment of diabetic nephropathy[J].Anhui Med Pharm J(安徽医药),2009,13(2):215-217.
|
| [24] |
Cheng SH,Hou FY,Zhang LJ.Investigation on curative effect of astragalus injection on ddiabetic nephrosis[J].Chin Tradit Pat Med(中成药),2000,22(3):207-209.
|
| [25] |
Lan T,Wu T,Gou H,et al.Andrographolide suppresses high glucose-induced fibronectin expression in mesangial cells via inhibiting the AP-1 pathway[J].J Cell Biochem,2013,114(11):2562-2568.
|
| [26] |
Hummel KP,Dickie MM,Coleman DL.Diabetes,a new mutation in the mouse[J].Science,1966,153(3740):1127-1128.
|
| [27] |
Brezniceanu ML,Liu F,Wei CC,et al.Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells[J].Diabetes, 2008,57(2):451-459.
|
下载:
